BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 241 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,360,705 | -24.4% | 192,190 | -24.8% | 0.00% | – |
| Q2 2023 | $1,799,994 | +17.3% | 255,681 | +39.0% | 0.00% | – |
| Q1 2023 | $1,534,134 | +1260.0% | 183,949 | +1772.1% | 0.00% | – |
| Q4 2022 | $112,803 | -47.8% | 9,826 | -43.0% | 0.00% | – |
| Q3 2022 | $216,000 | -10.0% | 17,247 | -23.9% | 0.00% | – |
| Q2 2022 | $240,000 | -90.5% | 22,672 | -85.4% | 0.00% | -100.0% |
| Q1 2022 | $2,519,000 | -15.9% | 154,952 | -28.3% | 0.00% | 0.0% |
| Q4 2021 | $2,995,000 | +3.8% | 216,194 | +7.7% | 0.00% | 0.0% |
| Q3 2021 | $2,886,000 | -9.2% | 200,771 | -0.1% | 0.00% | 0.0% |
| Q2 2021 | $3,177,000 | +54.8% | 200,931 | -0.4% | 0.00% | – |
| Q1 2021 | $2,052,000 | -41.7% | 201,799 | -57.3% | 0.00% | -100.0% |
| Q4 2020 | $3,519,000 | +118.4% | 472,377 | +0.8% | 0.00% | – |
| Q3 2020 | $1,611,000 | -29.6% | 468,686 | -2.4% | 0.00% | -100.0% |
| Q2 2020 | $2,287,000 | +1142.9% | 480,122 | +419.5% | 0.00% | – |
| Q1 2020 | $184,000 | -63.2% | 92,413 | -36.1% | 0.00% | – |
| Q4 2019 | $500,000 | -8.1% | 144,719 | -23.7% | 0.00% | – |
| Q3 2019 | $544,000 | -21.7% | 189,582 | +3.4% | 0.00% | – |
| Q2 2019 | $695,000 | -0.1% | 183,419 | +114.8% | 0.00% | – |
| Q1 2019 | $696,000 | +30.8% | 85,381 | +29.4% | 0.00% | – |
| Q4 2018 | $532,000 | +2.9% | 65,995 | -2.6% | 0.00% | – |
| Q3 2018 | $517,000 | +43.2% | 67,754 | +7.3% | 0.00% | – |
| Q2 2018 | $361,000 | +11.4% | 63,126 | -7.2% | 0.00% | – |
| Q1 2018 | $324,000 | +25.6% | 68,052 | +29.3% | 0.00% | – |
| Q4 2017 | $258,000 | -49.1% | 52,649 | -45.5% | 0.00% | – |
| Q3 2017 | $507,000 | +42.4% | 96,671 | +50.7% | 0.00% | – |
| Q2 2017 | $356,000 | -47.1% | 64,141 | -19.9% | 0.00% | – |
| Q1 2017 | $673,000 | -10.3% | 80,103 | -32.4% | 0.00% | – |
| Q4 2016 | $750,000 | +500.0% | 118,433 | +318.0% | 0.00% | – |
| Q3 2016 | $125,000 | +101.6% | 28,330 | +29.8% | 0.00% | – |
| Q2 2016 | $62,000 | -39.8% | 21,830 | -40.0% | 0.00% | – |
| Q1 2016 | $103,000 | -69.0% | 36,408 | +13.0% | 0.00% | – |
| Q4 2015 | $332,000 | -36.9% | 32,209 | -30.3% | 0.00% | – |
| Q3 2015 | $526,000 | -32.8% | 46,185 | -11.9% | 0.00% | – |
| Q2 2015 | $783,000 | +4.1% | 52,423 | -37.1% | 0.00% | – |
| Q1 2015 | $752,000 | +61.7% | 83,312 | +117.9% | 0.00% | – |
| Q4 2014 | $465,000 | +44.9% | 38,228 | +16.6% | 0.00% | – |
| Q3 2014 | $321,000 | +19.3% | 32,779 | +55.5% | 0.00% | – |
| Q2 2014 | $269,000 | -35.6% | 21,074 | -46.7% | 0.00% | – |
| Q1 2014 | $418,000 | +111.1% | 39,510 | +51.6% | 0.00% | – |
| Q4 2013 | $198,000 | -19.8% | 26,056 | -23.1% | 0.00% | – |
| Q3 2013 | $247,000 | +1664.3% | 33,902 | +270.5% | 0.00% | – |
| Q2 2013 | $14,000 | – | 9,151 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |